Invention is an essential feature of business. The best inventions are created when you mix talented people playing to their strengths in an environment of open collaboration, working in partnership with clients and suppliers with a clear focus on commercial goals.
Exciting and varied work that makes a difference. A collaborative culture where you can take on complex technical challenges and deliver commercial impact. That's life at TTP.
Intravenous delivery remains the dominant paradigm in oncology, but even with precision medicine few drugs pass late stage clinical trials. Karthik Chellappan proposes that early exploration of better administration routes could make all the difference.
What does the rise of 5G and new (LEO) space operators mean for the satellite and cellular industries and for next-generation IoT? TTP’s Adrian Hillier charts the way ahead.
When working with machine learning tools and algorithms, we often assume that only the machine is learning. Not so, argues Mark Hsieh. To achieve maximum value, we need to learn from the results generated by algorithms to better understand the problem we are trying to solve, for example in predicting disease progression in diabetes.
New LEO satellite networks promise high-speed broadband access for billions living beyond the reach of fibre and cellular networks. But the cost of User Terminals (UTs) for such satellite connections remains far beyond consumer budgets. Andrew Fell sketches how technical innovation, convergence in standards and network intelligence could pave the road to low-cost UTs for broadband from space.
TTP plc (TTP), a leading independent technology and product development company, has announced today that it has partnered with Quotient Ltd to develop and implement a state-of-the-art manufacturing facility for Quotient’s proprietary MosaiQ™ system.
TTP's Digital Health experts will be at Digital Health Pharma Congress at booth 433. Define and strengthen your place in the digital health ecosystem.
TTP's Desktop Biology team will be exhibiting on booth 3383 at AACC 2019. See how we can advance your biology.
Cellular Highways, TTP plc’s most recent spin out, is developing a new generation of automated high-throughput cell sorting instruments for research, diagnostic and therapeutic applications. Powered by a new microfluidic cell sorter technology, our instruments will reduce the cost and complexity of cell sorting and achieve far higher throughput than existing platforms.
